Where does Standard BioTools Canada Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Standard BioTools Canada Inc. ranks #25,278 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Standard BioTools Canada Inc. hold?

Standard BioTools Canada Inc. holds 11 US utility patents granted between 2023 and 2025, spanning 8 technology areas.

What is Standard BioTools Canada Inc.'s Innovation Score?

Standard BioTools Canada Inc. has an Innovation Score of 51.6 out of 100 (top 11% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Standard BioTools Canada Inc. focus on?

Standard BioTools Canada Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 11 patents, ranking #1,329 of 7,863 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Standard BioTools Canada Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Standard BioTools Canada Inc..

What does claim depth mean for Standard BioTools Canada Inc.'s patents?

Standard BioTools Canada Inc.'s patents average 21.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Standard BioTools Canada Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Standard BioTools Canada Inc.

USPTO PatentsView assignee record - 11 granted patents across 8 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Standard ranks #25,278 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 8 technology areas.

#25,278
of 49,997 US assignees by volume: Top 11%
by Innovation Score (51.6/100): 21.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R25278 · Foreign Corporation #25,278 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 11 grants
MID-PACK #25,278/49,997
PHOTO-FINISH Spiral Therapeutics
CPC-NARROW G01N · 8 areas
INNOV-PAR 51.6/100
CLAIMS-DENSE 21.6 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Spiral Therapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Standard’s 51.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (17%) Velocity 20.0 pts (39%) Breadth 10.0 pts (19%) Claim depth 13.0 pts (25%)

Qualcomm Incorporated · highest

85
Standard BioTools… · this assignee

52
3D Lighting… · lowest

7

What this shows Standard's Innovation Score is 51.6/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Standard?

Each dot is one of Standard’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Standard’s own 21.6 claims/patent is ABOVE the 15.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Standard vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Standard's grants concentrate

Standard BioTools Canada Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2024 (6 grants) versus a trough of 2 in 2023. By volume, Standard sits between Spiral Therapeutics, Inc. and Starpharma Pty Ltd..

Standard's three-year grant acceleration

Standard BioTools Canada Inc. shows 8 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Spiral Therapeuti…

11
Spookfish Innovat…

11
Sprout Pharmaceut…

11
Spühl

11
Standard Energy

11
Stanley Works (Eu…

11
Starbuzz® Tobacco

11
Starpharma Pty

11
Standard Biotools… ◀

11

What this shows Standard holds 11 patents at rank #25,292, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Standard

By rank, the assignees closest to #25,292 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Standard's primary technology class.

Standard's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

52 Top 11% higher than 89% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Standard BioTools Canada Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	2	18.2%
2024	6	54.5%
2025partial year	3	27.3%

Which technologies does Standard BioTools Canada Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 11

H01J - Electric Discharge Tubes OR Discharge Lamps 10

G02B - Optical Elements, Systems OR Apparatus 3

H05H - Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams 3

C07K - Peptides 2

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 2

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 1

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Standard BioTools Canada Inc.'s patent record in context - here's where to go next.

Standard BioTools Canada Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 100% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #25,278 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Standard BioTools Canada Inc. against Spiral Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 51.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.